Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report

Bibliographic Details
Title: Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report
Authors: Zauraiz Anjum, Charoo Iyer, Sidra Naz, Vikash Jaiswal, Gaurav Nepal, Maryrose Laguio‐vila, Sanjay Anandaram, Sahil Thapaliya
Source: Clinical Case Reports, Vol 10, Iss 4, Pp n/a-n/a (2022)
Publisher Information: Wiley, 2022.
Publication Year: 2022
Collection: LCC:Medicine
LCC:Medicine (General)
Subject Terms: COVID‐19, GBS, Moderna, mRNA, vaccine, Medicine, Medicine (General), R5-920
More Details: Abstract Guillain‐Barre syndrome (GBS) is an acquired inflammatory polyradiculoneuropathy that often follows infection with a virus or bacteria and in rare occasions, vaccination may precede GBS. We present a case of 80‐year‐old male patient who presented with chief complaints of progressive, ascending bilateral lower extremity paresthesia and weakness following first dose of Moderna vaccine. His symptoms got exacerbated after 2nd dose. Clinical examination and investigation findings including lumbar puncture, nerve conduction study, and electromyography were consistent with the diagnosis of GBS. The patient received treatment with intravenous immunoglobulin and there was significant improvement toward the end of 5th day. Though rare, this case report suggest that physician should remain vigilant for GBS following COVID‐19 vaccination.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2050-0904
Relation: https://doaj.org/toc/2050-0904
DOI: 10.1002/ccr3.5733
Access URL: https://doaj.org/article/b9b9aa40ca024624be17634327e72f1d
Accession Number: edsdoj.b9b9aa40ca024624be17634327e72f1d
Database: Directory of Open Access Journals
More Details
ISSN:20500904
DOI:10.1002/ccr3.5733
Published in:Clinical Case Reports
Language:English